drugset
drugset / Trial / NCT04504760

Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and PK of ONO-2910 in Japanese and Caucasian Subjects

NCT04504760 ↗

Phase 1 Completed 80 enrolled Ono Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To investigate safety, tolerability and pharmacokinetics in Japanese and Caucasian subjects when ONO-2910 is administered as single and multiple doses orally.

Timeline

Start
2020-07-10
Primary completion
2021-03-18
Completion
2021-03-18

Drugs

EvaluationDrugModalityDoseRoute
Subject ONO-2910 Small molecule — Oral

Indications

No indication recorded.